Prescribing information (package insert) - Norepinephrine Bitartrate
• WARNINGS AND PRECAUTIONS
Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only.
• ADVERSE EVENTS
To facilitate Adverse Event Reporting: www.fda.gov/medwatch or 1-800-FDA-1088.
• HOW SUPPLIED
Norepinephrine bitartrate injection solution is supplied as a sterile, nonpyrogenic solution that is clear, colorless at 250 mL in a Single-Dose Injection Solution Bag.
This product is Preservative-Free and Latex-Free.
• INGREDIENTS
Each 1 mL contains the equivalent of 32 mcg norepinephrine base, 50 mg dextrose, 236.8 mcg sodium chloride, 64 mcg sodium metabisulfite, and pH adjusters include hydrochloric acid and/or sodium hydroxide, if necessary.
• STORAGE AND HANDLING
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from light.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit.
Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains a precipitate.
• DOSAGE AND ADMINISTRATION.
FOR INTRAVENOUS USE ONLY. PRESERVATIVE-FREE INJECTION SOLUTION.
Rx Only
Rev. 03/15
CANTRELL DRUG COMPANY
LITTLE ROCK, AR 72207